Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1977 Nov;39(11):1205–1209. doi: 10.1136/hrt.39.11.1205

Metabolic and hormonal studies in patients with essential hypertension.

W Januszewicz, M Ciswicka-Sznajderman, B Wocial, M Sznajderman, H Ignatowska-Switalska, H Berent, Z Zukowska-Grojec, T Feltynowski
PMCID: PMC483397  PMID: 588376

Abstract

In 106 patients with essential hypertension and different plasma renin activity several hormonal and metabolic factors were studied: urinary excretion of catecholamines, blood levels of cholesterol and triglycerides, levels of glycaemia and insulinaemia after glucose load and plasma fibrinolytic activity. The plasma renin activity in 46.2 percent of patients was normal, whereas in 25.5 percent it was low, and in 28.3 percent it was high. In patients with high plasma renin activity the excretion of noradrenaline and adrenaline was relatively high while that of dopamine was low. Significantly lower triglyceride levels were found in patients with low plasma renin activity in comparison with those with high and normal plasma renin activity. There was also a statistically significant difference in the euglobulin lysis time which was shorter in patients with low and longest in patients with normal plasma renin activity. The results of the study show that patients with different plasma renin activity may also differ in some hormonal and metabolic values.

Full text

PDF
1205

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brunner H. R., Laragh J. H., Baer L., Newton M. A., Goodwin F. T., Krakoff L. R., Bard R. H., Bühler F. R. Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med. 1972 Mar 2;286(9):441–449. doi: 10.1056/NEJM197203022860901. [DOI] [PubMed] [Google Scholar]
  2. CARLSSON A., WALDECK B. A fluorimetric method for the determination of dopamine (3-hydroxytyramine). Acta Physiol Scand. 1958 Dec 15;44(3-4):293–298. doi: 10.1111/j.1748-1716.1958.tb01628.x. [DOI] [PubMed] [Google Scholar]
  3. Chakrabarti R., Hocking E. D., Fearnley G. R., Mann R. D., Attwell T. N., Jackson D. Fibrinolytic activity and coronary-artery disease. Lancet. 1968 May 11;1(7550):987–990. doi: 10.1016/s0140-6736(68)91104-5. [DOI] [PubMed] [Google Scholar]
  4. Crane M. G., Harris J. J., Johns V. J., Jr Hyporeninemic hypertension. Am J Med. 1972 Apr;52(4):457–466. doi: 10.1016/0002-9343(72)90036-8. [DOI] [PubMed] [Google Scholar]
  5. DeQuattro V., Miura Y. Neurogenic factors in human hypertension: mechanism or myth? Am J Med. 1973 Sep;55(3):362–378. doi: 10.1016/0002-9343(73)90136-8. [DOI] [PubMed] [Google Scholar]
  6. Doyle A. E., Jerums G., Johnston C. I., Louis W. J. Plasma renin levels and vascular complications in hypertension. Br Med J. 1973 Apr 28;2(5860):206–207. doi: 10.1136/bmj.2.5860.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. FEARNLEY G. R., BALMFORTH G., FEARNLEY E. Evidence of a diurnal fibrinolytic rhythm; with a simple method of measuring natural fibrinolysis. Clin Sci. 1957 Nov;16(4):645–650. [PubMed] [Google Scholar]
  8. Januszewicz W., Wocial B. Dopa, catecholamines and their metabolites in essential hypertension. Clin Sci Mol Med Suppl. 1975 Jun;2:295s–298s. doi: 10.1042/cs048295s. [DOI] [PubMed] [Google Scholar]
  9. Laragh J. H. Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med. 1973 Sep;55(3):261–274. doi: 10.1016/0002-9343(73)90128-9. [DOI] [PubMed] [Google Scholar]
  10. Michelakis A. M., Caudle J., Liddle G. W. In vitro stimulation of renin production by epinephrine, norepinephrine, and cyclic AMP. Proc Soc Exp Biol Med. 1969 Mar;130(3):748–753. doi: 10.3181/00379727-130-33647. [DOI] [PubMed] [Google Scholar]
  11. Mroczek W. J., Finnerty F. A., Catt K. J. Lack of association between plasma-renin and history of heart-attack or stroke in patients with essential hypertension. Lancet. 1973 Sep 1;2(7827):464–468. doi: 10.1016/s0140-6736(73)92069-2. [DOI] [PubMed] [Google Scholar]
  12. Spöttl F., Holzknecht F., Braunsteiner H. Inhibitors of the plasminogen-activation in patients with primary "carbohydrate-induced" hypertriglyceridemia. J Atheroscler Res. 1968 Sep-Oct;8(5):821–826. doi: 10.1016/s0368-1319(68)80044-4. [DOI] [PubMed] [Google Scholar]
  13. von EULER U., LISHAJKO F. Improved technique for the fluorimetric estimation of catecholamines. Acta Physiol Scand. 1961 Apr;51:348–355. doi: 10.1111/j.1748-1716.1961.tb02128.x. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES